DE1415026U - - Google Patents

Info

Publication number
DE1415026U
DE1415026U DENDAT1415026D DE1415026DU DE1415026U DE 1415026 U DE1415026 U DE 1415026U DE NDAT1415026 D DENDAT1415026 D DE NDAT1415026D DE 1415026D U DE1415026D U DE 1415026DU DE 1415026 U DE1415026 U DE 1415026U
Authority
DE
Germany
Prior art keywords
änut
tximtmf
tmiohm
iti8u
awajmemtwilw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1415026D
Other languages
German (de)
English (en)
Publication of DE1415026U publication Critical patent/DE1415026U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DENDAT1415026D Active DE1415026U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1415026U true DE1415026U (cg-RX-API-DMAC7.html)

Family

ID=725266

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1415026D Active DE1415026U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1415026U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
US10668051B2 (en) Modulators of calcium release-activated calcium channel
DE69627035T2 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
DK2513140T3 (en) Double-acylated GLP-1 derivatives
ES2817700T3 (es) Derivados de 2-(pirimidin-5-il)-tiopirimidina como moduladores de Hsp70 y Hsc70 para el tratamiento de trastornos proliferativos
US20090170849A1 (en) Quinazolinone derivatives having b-raf inhibitory activity
US20080275022A1 (en) Substituted Quinazolones as Anti-Cancer Agents
US20050020612A1 (en) 4-Aryliquinazolines and the use thereof as nhe-3 inhibitors
US20080306096A1 (en) Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
KR20110003340A (ko) Ｒａｆ 키나아제 조절제로서의 퀴나졸린 유도체 및 그의 사용방법
US20090149484A1 (en) Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
US20090163525A1 (en) Substituted quinazolines with anti-cancer activity
US20150126563A1 (en) Small molecule inhibitors of the pleckstrin homology domain and methods for using same
Harker et al. β-Peptides with improved affinity for hDM2 and hDMX
NO322569B1 (no) Nye <alfa>-aminosyreforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
AU2010258027B2 (en) Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
CA2978184A1 (en) Modified therapeutic agents and compositions thereof
DE1415026U (cg-RX-API-DMAC7.html)
US20150045393A1 (en) Novel Cysteine Protease Inhibitors and Uses Thereof
US10745410B2 (en) Substituted [5,6]cyclic-4(3H)-pyrimidinones as anticancer agents
US20050113396A1 (en) 2-Guanidino-4-heterocyclylquinazolines
CA2635916A1 (en) Triazoloanilinopyrimidine derivatives for use as antiviral agents
ES2980112T3 (es) Compuestos y su uso para el tratamiento de la deficiencia en alfa1-antitripsina
US8242142B2 (en) Cyclohexylamines, phenylamines and uses thereof
US20250236600A1 (en) Substituted vinyl piperazine-piperidine urea derivatives as anticancer agents
US10858312B1 (en) Gossypol isocyanate ester compounds with antileukemic activities and a method of preparing the same